Watchlist Price Alert

Dr. Reddy's Laboratories ... (RDY)

NYSE: RDY · Real-Time Price · USD

14.44

0.05 (0.35%)

At close: May 16, 2025, 3:59 PM

14.37

-0.48%

Pre-market: May 19, 2025, 08:52 AM EDT

Dr. Reddy's Laboratories Income Statement

Financials in INR. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Revenue	279.16B	245.88B	214.39B	189.72B	174.6B	153.85B	142.03B	140.81B	154.71B
Cost of Revenue	115.56B	42.91B	100.55B	86.64B	80.59B	70.42B	65.72B	62.45B	62.43B
Gross Profit	163.61B	202.97B	113.84B	103.08B	94.01B	83.43B	76.3B	78.36B	92.28B
Operating Income	67.73B	96.28B	40.82B	36.06B	37.05B	20.89B	11.92B	13.5B	29.62B
Interest Income	2.28B	1.18B	3.08B	2.62B	888M	2.28B	540M	558M	1.4B
Pretax Income	71.87B	60.48B	32.3B	28.32B	18.03B	22.44B	14.34B	14.65B	27.14B
Net Income	55.68B	45.07B	23.57B	17.24B	19.5B	18.8B	9.81B	12.04B	20.01B
Selling & General & Admin	77.2B	105.93B	62.08B	54.56B	50.13B	48.89B	46.91B	46.37B	45.7B
Research & Development	22.87B	19.38B	17.48B	16.54B	15.41B	15.61B	18.27B	19.55B	17.83B
Other Expenses	-4.2B	-7.7B	-2.76B	-982M	-4.29B	-691M	-843M	-1.15B	-986M
Operating Expenses	95.88B	117.61B	76.8B	70.12B	61.25B	62.54B	64.39B	64.86B	62.66B
Interest Expense	1.71B	1.43B	958M	970M	983M	1.16B	788M	634M	826M
Selling & Marketing Expenses	n/a	59.47B	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	211.44B	160.52B	177.35B	156.76B	141.84B	132.96B	130.11B	127.31B	125.09B
Income Tax Expense	16.19B	15.41B	8.73B	9.18B	-1.47B	3.65B	4.54B	2.61B	7.13B
Shares Outstanding (Basic)	833.54M	830.17M	829.41M	829.22M	828.79M	829.58M	829.23M	833.24M	852.74M
Shares Outstanding (Diluted)	833.54M	831.91M	831.69M	831.58M	830.41M	830.98M	830.93M	834.99M	855.36M
EPS (Basic)	66.80	54.29	28.42	20.79	23.53	22.66	11.83	14.45	23.47
EPS (Diluted)	66.80	54.17	28.34	20.73	23.48	22.62	11.80	14.42	23.40
EBITDA	88.42B	74.43B	47.74B	45.71B	41.78B	31.86B	23.73B	24.55B	40.17B
EBIT	73.58B	61.8B	33.26B	27.38B	19.02B	23.33B	15.13B	15.29B	27.97B
Depreciation & Amortization	14.84B	12.64B	11.82B	12.8B	12.47B	12.19B	11.71B	11.28B	10.25B